92 related articles for article (PubMed ID: 1649765)
1. Clearance of S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913) in rats.
Lam TT; Liu D; Brody MA; Chu R; Tso MO
Exp Eye Res; 1991 Jun; 52(6):661-7. PubMed ID: 1649765
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic profile of amifostine.
Shaw LM; Bonner H; Lieberman R
Semin Oncol; 1996 Aug; 23(4 Suppl 8):18-22. PubMed ID: 8783662
[TBL] [Abstract][Full Text] [Related]
3. In vitro metabolism of the phosphorothioate radioprotectors WR-2721 and WR-3689.
Livesey JC; Rasey JS; Vertrees S; Freeman LM; Magee S; Nelson NJ; Chin L; Grunbaum Z; Krohn KA
Pharmacol Ther; 1988; 39(1-3):215-7. PubMed ID: 2849127
[No Abstract] [Full Text] [Related]
4. Inhibition of lens opacification in x-irradiated rats treated with WR-77913.
Osgood TB; Menard TW; Clark JI; Krohn KA
Invest Ophthalmol Vis Sci; 1986 Dec; 27(12):1780-4. PubMed ID: 3025129
[TBL] [Abstract][Full Text] [Related]
5. Phase separation inhibitors and lens transparency.
Clark JI; Livesey JC; Steele JE
Optom Vis Sci; 1993 Nov; 70(11):873-9. PubMed ID: 8302522
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of phase separation by reagents that prevent X-irradiation cataract in vivo.
Clark JI; Osgood TB; Trask SJ
Exp Eye Res; 1987 Dec; 45(6):961-7. PubMed ID: 2828097
[TBL] [Abstract][Full Text] [Related]
7. Delay or inhibition of rat lens opacification using pantethine and WR-77913.
Clark JI; Livesey JC; Steele JE
Exp Eye Res; 1996 Jan; 62(1):75-84. PubMed ID: 8674515
[TBL] [Abstract][Full Text] [Related]
8. Determination of the cytoprotective agent WR-2721 (Amifostine, Ethyol) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography.
Souid AK; Newton GL; Dubowy RL; Fahey RC; Bernstein ML
Cancer Chemother Pharmacol; 1998; 42(5):400-6. PubMed ID: 9771955
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of radiation cataractogenesis by WR-77913.
Livesey JC; Wiens LW; Von Seggern DJ; Barlow WE; Arnold AM
Radiat Res; 1995 Jan; 141(1):99-104. PubMed ID: 7997522
[TBL] [Abstract][Full Text] [Related]
10. Radioprotection against cataract formation by WR-77913 in gamma-irradiated rats.
Menard TW; Osgood TB; Clark JI; Spence AM; Steele JE; Krohn KA; Livesey JC
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1483-6. PubMed ID: 3019964
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a method for measuring the radioprotective metabolite WR-1065 in plasma using chemical derivatization combined with UHPLC-MS/MS.
Simon ES; Reyna D; Lister RJ; Harteg C; Lipka E
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1080():82-89. PubMed ID: 29482122
[TBL] [Abstract][Full Text] [Related]
12. Sodium hydrogen-S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection.
Mendiondo OA; Connor AM; Grigsby P
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):553-5. PubMed ID: 6286552
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatographic assay using electrochemical detection for the combined measurement of amifostine, WR 1065 and the disulfides in plasma.
Korst AE; Vermorken JB; van der Vijgh WJ
J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):167-74. PubMed ID: 9200531
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the protective effects of three phosphorothioate radioprotectors in the RIF-1 tumor.
Rasey JS; Krohn KA; Magee S; Nelson N; Chin L
Radiat Res; 1986 Nov; 108(2):167-75. PubMed ID: 3024202
[TBL] [Abstract][Full Text] [Related]
15. Light damage in the rat retina: effect of a radioprotective agent (WR-77913) on acute rod outer segment disk disruptions.
Remé CE; Braschler UF; Roberts J; Dillon J
Photochem Photobiol; 1991 Jul; 54(1):137-42. PubMed ID: 1658823
[TBL] [Abstract][Full Text] [Related]
16. Comparison of behavioral and radioprotective effects of WR-2721 and WR-3689.
McDonough JH; Mele PC; Franz CG
Pharmacol Biochem Behav; 1992 Jun; 42(2):233-43. PubMed ID: 1321450
[TBL] [Abstract][Full Text] [Related]
17. Analysis of S-35 labeled WR-2721 and its metabolites in biological fluids.
Anderson KW; Krohn KA; Grunbaum Z; Phillips RB; Mahler PA; Menard TW; Spence AM; Rasey JS
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1511-5. PubMed ID: 6090353
[TBL] [Abstract][Full Text] [Related]
18. In vivo and photophysical studies on photooxidative damage to lens proteins and their protection by radioprotectors.
Roberts JE; Kinley JS; Young AR; Jenkins G; Atherton SJ; Dillon J
Photochem Photobiol; 1991 Jan; 53(1):33-8. PubMed ID: 1851303
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient.
Korst AE; Gall HE; Vermorken JB; van der Vijgh WJ
Cancer Chemother Pharmacol; 1996; 39(1-2):162-6. PubMed ID: 8995515
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of amifostine and its analogues on sulfur mustard toxicity in vitro and in vivo.
Bhattacharya R; Rao PV; Pant SC; Kumar P; Tulsawani RK; Pathak U; Kulkarni A; Vijayaraghavan R
Toxicol Appl Pharmacol; 2001 Oct; 176(1):24-33. PubMed ID: 11578146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
